Filings & corporate actions
- 2 NovresultsResults · Q2 FY27 · consolidated and standalone-1.0%NSE
- 14 OctshareholdingShareholding · 30 Sept 2026-1.2%NSE
- 18 SeptdividendDividend · ₹2.00 per share · record 18 Sept 20260.0%
- 14 AugresultsResults · Q1 FY27 · consolidated and standalone+3.3%NSE
- 17 JulshareholdingShareholding · 30 Jun 2026-1.3%NSE
- 25 MayresultsResults · Q4 FY26 · consolidated and standalone-0.9%NSE
- 6 AprshareholdingShareholding · 31 Mar 2026+2.9%NSE
- 5 FebresultsResults · Q3 FY26 · consolidated and standalone-2.8%NSE
- 10 JanshareholdingShareholding · 31 Dec 2025-1.8%NSE
Reaction to results · all yearsrose on day 0 in 7 of 21 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q2 FY27 | 2 Nov 2026 | -1.0% | -3.7% | — | 7.4× |
| Q1 FY27 | 14 Aug 2026 | +3.3% | +0.9% | -1.2% | 3.7× |
| Q4 FY26 | 25 May 2026 | -0.9% | -2.3% | -2.9% | 8.2× |
| Q3 FY26 | 5 Feb 2026 | -2.8% | -7.2% | -18.4% | 2.9× |
| Q2 FY26 | 7 Nov 2025 | +7.6% | +14.2% | 0.0% | 44.1× |
| Q1 FY26 | 11 Aug 2025 | -7.3% | -5.4% | -2.9% | 1.8× |
| Q4 FY25 | 12 May 2025 | -7.6% | -14.3% | -6.3% | 7.6× |
| Q3 FY25 | 12 Feb 2025 | -5.2% | -10.4% | -13.9% | 1.8× |
| Q2 FY25 | 25 Oct 2024 | +6.3% | +16.7% | +28.8% | 2.5× |
| Q1 FY25 | 6 Aug 2024 | +5.4% | +2.9% | +18.4% | 2.1× |
| Q4 FY24 | 18 May 2024 | -1.8% | -4.9% | +7.3% | 1.8× |
| Q3 FY24 | 12 Feb 2024 | +1.4% | -1.4% | -14.9% | 0.7× |
| Q2 FY24 | 3 Nov 2023 | -6.0% | -9.3% | -6.9% | 3.1× |
| Q1 FY24 | 12 Aug 2023 | -3.8% | +10.9% | +24.1% | 1.2× |
| Q4 FY23 | 27 May 2023 | +4.0% | +11.1% | +12.7% | 1.0× |
| Q3 FY23 | 13 Feb 2023 | -4.2% | -6.9% | -5.5% | 1.9× |
| Q2 FY23 | 9 Nov 2022 | -2.5% | -6.2% | -4.5% | 2.6× |
| Q1 FY23 | 5 Aug 2022 | -3.6% | -9.7% | -4.3% | 1.7× |
| Q4 FY22 | 29 May 2022 | +4.0% | +6.6% | +1.5% | 1.0× |
| Q3 FY22 | 1 Feb 2022 | -1.5% | -0.3% | -12.2% | 1.8× |
| Q2 FY22 | 12 Oct 2021 | -6.7% | -10.8% | -13.1% | 4.7× |
| Average | -1.1% | -1.4% | -0.7% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q2 FY27
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | +13.7% | +17.2% | +18.2% | — | — | — |
| Profit | +19.1% | +19.4% | +11.3% | — | — | — |
Key data
Delivery percentage
Over the last 20 sessions KRSNAA settled 53.7% of its traded quantity, which is above average for an NSE equity. Its one-year average is 57.5%, so recent sessions are running 3.9 points lower than usual. The latest session ranks higher than 44% of the 1,302 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
Dividends, deals & holders
Performance returns
| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | +0.66% | -1.83% | +0.66% | -5.63% | -7.63% | -35.62% |
Valuation
Ownership
Quarterly results · consolidated
| Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 181.2 | 192.6 | 235.5 | 271.0 |
| YoY chg | +3.8% | +3.5% | +22.1% | +31.5% |
| Net profit (₹ Cr) | 15.2 | 41.7 | 16.6 | 24.6 |
| YoY chg | -21.5% | +101.8% | -19.3% | +2.7% |
| Net margin | 8.4% | 21.7% | 7.0% | 9.1% |
| EPS | 4.66 | 12.70 | 5.04 | 7.54 |
Shareholding over time
By quarter
30 Sept 2026 · promoter 27.11% · public 72.89%- Promoter
- Public and others
- Promoter
- 27.11%
- Public
- 72.89%
- Promoter change
- 0.00 pp
- Filed
- 14 Oct 2026
- FII
- 3.84%
- DII
- 14.50%
- Promoter pledged
- 0.00%
Who the public is
- Mutual funds
- 10.17%
- Insurance
- 2.67%
- FPI
- 3.84%
- Retail ≤ ₹2L
- 19.46%
- HNI > ₹2L
- 9.12%
- NRI
- 1.39%
- Bodies corporate
- 22.69%
- Shareholders
- 50,671
0.00 pp QoQ
0.00 pp QoQ
-0.44 pp QoQ
-0.69 pp QoQ
+1.42 pp QoQ
-0.20 pp QoQ
+0.86 pp QoQ
-5.5% QoQ
Major holders
As of 30 Sept 2026| Holder | Type | Holding | Shares |
|---|---|---|---|
| RAJENDRA KHIVRAJ MUTHA | Promoter · Individual | 24.75% | 80.30L |
| PHI CAPITAL TRUST - PHI CAPITAL GROWTH FUND - I | Corporate | 15.37% | 49.85L |
| TATA MUTUAL FUND - TATA SMALL CAP FUND | Mutual fund | 8.04% | 26.08L |
| KRSNA DIAGNOSTICS (MUMBAI) PRIVATE LIMITED | Promoter · Corporate | 2.36% | 7.66L |
| AMICORP CAPITAL (MAURITIUS) LIMITED | FPI | 2.18% | 7.06L |
| HDFC LIFE INSURANCE COMPANY LIMITED | Insurance | 2.04% | 6.63L |
| BANDHAN SMALL CAP FUND | Mutual fund | 1.98% | 6.41L |
| MEDIMAZE SOLUTIONS PRIVATE LIMITED | Corporate | 1.03% | 3.33L |
Every promoter-group member, and each public holder above 1%, as filed.
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.
Dividends
| Financial year | Payments | Declared | Adjusted |
|---|---|---|---|
| FY2026-27 | 1 | ₹2.00 | ₹2.00 |
| FY2025-26 | 1 | ₹2.75 | ₹2.75 |
| FY2024-25 | 1 | ₹2.50 | ₹2.50 |
| FY2023-24 | 1 | ₹2.75 | ₹2.75 |
| FY2022-23 | 1 | ₹2.50 | ₹2.50 |
| Ex-date | Record date | Declared | Adjusted |
|---|---|---|---|
| 18 Sept 2026 | 18 Sept 2026 | ₹2.00 | ₹2.00 |
| 12 Sept 2025 | — | ₹2.75 | ₹2.75 |
| 13 Sept 2024 | — | ₹2.50 | ₹2.50 |
| 15 Sept 2023 | — | ₹2.75 | ₹2.75 |
| 15 Sept 2022 | — | ₹2.50 | ₹2.50 |
Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.
Book closures & record dates
NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.
Insider trades
- Insiders net, 30d
- ₹0
- Insiders net, 90d
- ₹0
- Promoters net, 90d
- ₹0
- Insider buyers, 90d
- 0
- Last promoter buy
- 23 months ago
- Disclosures on record
- 13
| Broadcast | Person | Side | Shares | Value | Price | Holding before → after | Stake | Regulation |
|---|---|---|---|---|---|---|---|---|
| 31 Dec 2024 | Krsna Diagnostics (Mumbai) Private LimitedPromoter | Buy | 22.9K | ₹2.0Cr | 870.89 | 7.43L → 7.66L | 2.37%+0.07 pp | 7(2)told 30 Dec 2024 |
| 6 Jun 2024 | KRSNA DIAGNOSTICS (MUMBAI) PRIVATE LIMITEDPromoter | Buy | 45.0K | ₹2.4Cr | 540.86 | 6.98L → 7.43L | 2.30%+0.14 pp | 7(2)told 6 Jun 2024 |
| 21 Feb 2022 | Phi Capital Trust - Phi Capital Growth Fund - 1Other | Buy | 7.7K | ₹46.5L | 603.25 | 49.77L → 49.85L | 15.88%+0.02 pp | 7(3)told 21 Feb 2022 |
| 21 Feb 2022 | Phi Capital Trust - Phi Capital Growth Fund - 1Other | Buy | 10.0K | ₹60.5L | 604.94 | 49.67L → 49.77L | 15.85%+0.03 pp | 7(3)told 21 Feb 2022 |
| 18 Feb 2022 | Phi Capital Trust - Phi Capital Growth Fund - 1Other | Buy | 10.0K | ₹61.5L | 615.16 | 49.57L → 49.67L | 15.82%+0.03 pp | 7(3)told 17 Feb 2022 |
| 18 Feb 2022 | Phi Capital Trust - Phi Capital Growth Fund - 1Other | Buy | 5.3K | ₹32.8L | 619.92 | 49.52L → 49.57L | 15.79%+0.02 pp | 7(3)told 17 Feb 2022 |
| 16 Feb 2022 | Phi Capital Trust - Phi Capital Growth Fund - 1Other | Buy | 25.0K | ₹1.6Cr | 640.73 | 49.27L → 49.52L | 15.77%+0.08 pp | 7(3)told 15 Feb 2022 |
| 16 Feb 2022 | Phi Capital Trust - Phi Capital Growth Fund - 1Other | Buy | 7.2K | ₹46.1L | 643.43 | 49.20L → 49.27L | 15.69%+0.02 pp | 7(3)told 15 Feb 2022 |
| 10 Feb 2022 | Phi Capital Trust - Phi Capital Growth Fund - 1Other | Buy | 50.0K | ₹3.3Cr | 658.80 | 48.70L → 49.20L | 15.67%+0.16 pp | 7(3)told 10 Feb 2022 |
| 10 Feb 2022 | Phi Capital Trust - Phi Capital Growth Fund - 1Other | Buy | 1.8K | ₹11.6L | 652.09 | 48.68L → 48.70L | 15.51%+0.01 pp | 7(3)told 10 Feb 2022 |
| 4 Jan 2022 | Phi Capital Trust �� Phi Capital Growth Fund �� 1Other | Buy | 25.0K | ₹1.8Cr | 727.58 | 48.43L → 48.68L | 15.50%+0.08 pp | 7(3)told 3 Jan 2022 |
| 4 Jan 2022 | Phi Capital Trust �� Phi Capital Growth Fund �� 1Other | Buy | 75.0K | ₹5.6Cr | 743.87 | 47.68L → 48.43L | 15.42%+0.24 pp | 7(3)told 3 Jan 2022 |
SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.
How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session
Bulk & block deals · 12 Jun 2024
CSV| Date | Deal | Client | Quantity | Price | Value |
|---|---|---|---|---|---|
| 12 Jun 2024 | Sell · bulk | KITARA PIIN 1104 | 3.72L | 600.69 | ₹22.3Cr |
| 3 Oct 2023 | Buy · block | EAST LANE CAPITAL LLP | 1.50L | 675.00 | ₹10.1Cr |
| 3 Oct 2023 | Sell · block | MEDIMAZE SOLUTIONS PRIVATE LIMITED | 1.50L | 675.00 | ₹10.1Cr |
| 28 Sept 2023 | Sell · bulk | INVESCO MUTUAL FUND | 1.95L | 675.02 | ₹13.2Cr |
| 28 Sept 2023 | Buy · bulk | MIV INVESTMENT SERVICES PRIVATE LIMITED | 1.60L | 675.00 | ₹10.8Cr |
| 9 May 2023 | Sell · bulk | SOMERSET INDUS HEALTHCARE FUND I LIMITED | 8.91L | 495.27 | ₹44.1Cr |
| 9 May 2023 | Buy · bulk | ACM GLOBAL FUND VCC | 6.91L | 495.25 | ₹34.2Cr |
| 16 Aug 2021 | Buy · bulk | BIRLA SUN LIFE INSURANCE CO LTD | 2.30L | 1,023.34 | ₹23.5Cr |
| 16 Aug 2021 | Sell · bulk | ALPHAGREP SECURITIES PRIVATE LIMITED | 2.21L | 1,033.09 | ₹22.8Cr |
| 16 Aug 2021 | Buy · bulk | ALPHAGREP SECURITIES PRIVATE LIMITED | 2.21L | 1,033.01 | ₹22.8Cr |
| 16 Aug 2021 | Sell · bulk | NK SECURITIES RESEARCH PRIVATE LIMITED | 2.03L | 1,031.77 | ₹21.0Cr |
| 16 Aug 2021 | Buy · bulk | NK SECURITIES RESEARCH PRIVATE LIMITED | 2.03L | 1,031.31 | ₹20.9Cr |
A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.
Takeover-code disclosures
Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.
Every stock on this session →Short selling, lending & margin
Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.
Exchange surveillance
No surveillance measure applies to KRSNAA.
Price band: 20% · not in the F&O ban.
From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.
Every stock on this session →Financials · quarterly statement
| Q3 FY24 | Q4 FY24A | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25A | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26A | Q1 FY27 | Q2 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 158.3 | 166.3 | 170.2 | 186.3 | 174.5 | 186.1 | 193.0 | 206.0 | 181.2 | 192.6 | 235.5 | 271.0 | |
| Other income | 4.1 | 4.3 | 7.3 | 4.6 | 9.2 | 4.4 | 4.0 | 4.2 | 3.8 | 31.5 | 7.2 | 6.2 | |
| Total income | 162.4 | 170.6 | 177.5 | 190.9 | 183.7 | 190.5 | 196.9 | 210.2 | 185.0 | 224.1 | 242.8 | 277.1 | |
| Total expenses | 146.3 | 148.0 | 154.3 | 165.5 | 158.3 | 161.9 | 169.5 | 178.6 | 165.2 | 172.4 | 220.3 | 244.4 | |
| └ Finance costs | 4.1 | 7.3 | 5.3 | 6.4 | 6.1 | 6.8 | 6.3 | 8.2 | 7.8 | 12.1 | 14.8 | 15.5 | |
| └ Depreciation | 21.2 | 18.1 | 21.5 | 22.2 | 22.7 | 22.0 | 21.6 | 23.6 | 22.7 | 22.6 | 28.0 | 29.1 | |
| Profit before tax | 16.1 | 22.6 | 23.2 | 25.4 | 25.5 | 28.6 | 27.4 | 31.6 | 19.8 | 51.7 | 22.4 | 32.8 | |
| Tax expense | 3.1 | 3.9 | 5.3 | 5.8 | 6.1 | 7.9 | 6.9 | 7.6 | 4.4 | 10.0 | 5.9 | 8.2 | |
| Net profit | 13.0 | 18.7 | 17.9 | 19.6 | 19.4 | 20.7 | 20.5 | 23.9 | 15.2 | 41.7 | 16.6 | 24.6 | |
| EPS | 4.09 | 5.80 | 5.55 | 6.07 | 6.01 | 6.40 | 6.35 | 7.38 | 4.72 | 12.86 | 5.10 | 7.64 | |
| Net margin | 8.19% | 11.26% | 10.53% | 10.52% | 11.13% | 11.11% | 10.63% | 11.62% | 8.41% | 21.66% | 7.03% | 9.07% | |
| PBT margin | 10.17% | 13.59% | 13.63% | 13.63% | 14.60% | 15.37% | 14.21% | 15.32% | 10.91% | 26.85% | 9.52% | 12.09% | |
| Tax rate | 19.39% | 17.16% | 22.76% | 22.86% | 23.80% | 27.71% | 25.18% | 24.14% | 22.45% | 19.31% | 26.24% | 24.97% |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 2 Nov 2026.
Balance sheet & cash flow · half-yearly
Balance sheet
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 909.9 | 1,077.5 | 1,171.9 | 1,294.5 | 1,281.6 | 1,506.7 | 1,823.7 | 2,063.6 | |
| Current assets | 225.8 | 432.0 | 421.2 | 417.3 | 414.5 | 576.7 | 738.3 | 765.2 | |
| └ Cash & equivalents | 22.7 | 30.3 | 2.4 | 11.3 | 3.8 | 10.6 | 30.2 | 77.4 | |
| └ Other bank balances | 86.1 | 172.2 | 51.2 | 51.3 | 64.6 | 119.4 | 330.5 | 114.2 | |
| └ Current investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| └ Trade receivables | 73.1 | 158.7 | 176.3 | 243.5 | 277.7 | 358.3 | 295.5 | 474.6 | |
| └ Inventories | 25.1 | 36.4 | 35.8 | 30.7 | 29.5 | 31.5 | 26.7 | 33.3 | |
| Total equity | 738.7 | 755.3 | 809.8 | 840.8 | 882.8 | 923.0 | 980.4 | 1,038.6 | |
| └ Attributable to owners | 738.7 | 755.3 | 809.8 | 840.8 | 882.8 | 923.0 | 980.4 | 1,038.6 | |
| └ Non-controlling interest | — | 0.0 | 0.0 | — | 0.0 | 0.0 | 0.0 | 0.0 | |
| └ Share capital | 15.7 | 15.7 | 16.1 | 16.1 | 16.1 | 16.2 | 16.2 | 16.2 | |
| Borrowings | 32.5 | 109.2 | 159.8 | 216.1 | 203.5 | 285.7 | 534.3 | 596.4 | |
| └ Current | 8.2 | 71.3 | 117.9 | 181.2 | 156.4 | 196.8 | 66.0 | 169.1 | |
| └ Non-current | 24.3 | 38.0 | 41.9 | 34.9 | 47.2 | 88.9 | 468.3 | 427.4 | |
| Trade payables | 62.1 | 110.9 | 82.3 | 92.8 | 97.1 | 139.6 | 63.2 | 231.7 | |
| Current liabilities | 99.2 | 240.7 | 281.5 | 381.1 | 305.4 | 407.5 | 275.2 | 482.2 | |
| Total liabilities | 171.2 | 322.2 | 362.1 | 453.8 | 398.8 | 583.7 | 843.3 | 1,024.9 | |
| Net debt | (76.3) | (93.3) | 106.2 | 153.5 | 135.1 | 155.8 | 173.6 | 404.8 | |
| Debt / equity | 0.04 | 0.14 | 0.20 | 0.26 | 0.23 | 0.31 | 0.55 | 0.57 | |
| Current ratio | 2.28 | 1.80 | 1.50 | 1.09 | 1.36 | 1.42 | 2.68 | 1.59 |
Cash flow, year to date
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 76.3 | 0.1 | 24.3 | 19.7 | 87.3 | 51.9 | 143.1 | 78.8 | |
| └ Capex | (141.4) | (89.9) | (193.9) | (54.6) | (126.6) | (103.6) | (219.3) | (250.3) | |
| Free cash flow | (65.1) | (89.8) | (169.5) | (34.9) | (39.3) | (51.7) | (76.2) | (171.5) | |
| Investing cash flow | (108.9) | (38.6) | (128.9) | (54.7) | (99.6) | (104.5) | (396.0) | (86.2) | |
| Financing cash flow | (33.1) | 46.1 | 84.2 | 43.9 | 13.8 | 59.3 | 279.3 | 54.6 | |
| └ Dividends paid | (7.8) | 0.0 | (8.6) | (0.5) | (8.1) | (0.7) | (8.9) | 0.0 | |
| └ Buybacks | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net change in cash | (65.7) | 7.6 | (20.3) | 8.9 | 1.5 | 6.7 | 26.4 | 47.2 |
From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.
Announcements & board meetings
As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.
Every stock on this session →KRSNAA at a glance
- KRSNAA closed at ₹519.05 on 20 Nov 2026, +0.66% on the day, -35.6% over one year, 38.1% below its 52-week high of ₹838.
- Delivery was 53.3% of traded quantity on 20 Nov 2026, the 44th percentile of its own 1,302 sessions with a reading (20-session average 53.7%, 1-year average 57.5%).
- Market capitalisation is ₹1,684 crore at a trailing P/E of 17.2 (trailing EPS ₹30.24).
- Q2 FY27 results (consolidated, filed 2 Nov 2026): revenue ₹271 crore (+31.5% year on year), net profit ₹25 crore (+2.7%); the price moved -1.0% on the first session after.
- Promoters held 27.11% at 30 Sept 2026, unchanged on the previous filing.
- Q3 FY27 results are expected between 1 Feb 2027 and 13 Feb 2027, going by past filing dates — an estimate, not an announcement.
About
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.
More in Healthcare Services
- APAPOLLOHOSPApollo Hospitals Enterprise Limited9,200.00+5.29%
- MAMAXHEALTHMax Healthcare Institute Limited1,081.00+3.88%
- PAPARASHLTHPARASHLTH844.65+1.16%
- FOFORTISFortis Healthcare Limited825.00+1.87%
- SYSYNGENESyngene International Limited451.70+3.28%
- ASASTERDMAster DM Quality Care Limited779.30+5.41%
- MAMANIPALHOSManipal Health Enterprises Limited702.20+0.83%
- LALALPATHLABDr. Lal Path Labs Ltd.2,006.00+2.18%
- THTHYROCAREThyrocare Technologies Limited528.45+4.67%
- ININDGNIndegene Limited657.65+1.90%
- MEMEDANTAGlobal Health Limited1,480.20+0.13%
- NHNHNarayana Hrudayalaya Ltd.1,943.70+3.77%
All Healthcare Services stocks on the NSEAll Healthcare stocks on the NSE